News

Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
The Business Times1d
US pharma tariffs would raise US drug costs by US$51 billion annually, report finds
LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, ...
AOL1d
Exclusive-US pharma tariffs would raise US drug costs by $51 billion annually, report finds
LONDON (Reuters) -A 25% U.S. tariff on pharmaceutical ... a trade lawyer at law firm Sidley Austin, which is advising companies on their submissions to the Commerce Department.
Taiwan News4d
Admiral Group agrees to sell its U.S. motor business to JC Flowers
Admiral Group plc announces that it has entered into an agreement to sell its U.S. motor insurance business, including Elephant Insurance Company and Elephant Insurance Services (“Elephant”), to J.C.
J.C. Flowers & Co.: Admiral Group agrees to sell its U.S. motor business to J.C. Flowers
Admiral Group plc announced today that it has entered into an agreement to sell its U.S. motor insurance business, including Elephant ...
Cadwalader Real Estate Finance Team Decamps to Sidley Austin (2)
Sidley Austin is picking up a 14-lawyer real estate finance group from Cadwalader as the firm continues to execute on its ...
US pharma tariffs would raise US drug costs by $51 bn annually: Report
Pharmaceutical products have long been spared from trade wars due to the potential harms, but he has repeatedly threatened a ...
PE Hub2d
Vector Capital snaps up software firm Bigtincan
David Keane serves as CEO and co-founder of Bigtincan. Vector Capital was advised by Johnson Winter Slattery and Sidley Austin LLP as legal counsel, Alvarez & Marsal as financial advisor ...